Cetera Investment Advisers
XBI icon

Cetera Investment Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cetera Investment Advisers’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Sell
162,025
-229
-0.1% -$31K 0.02% 638
2026
Q1 		$20.7M Sell
162,254
-927
-0.6% -$116K 0.02% 663
2025
Q4 		$19.9M Buy
163,181
+9,532
+6% +$1.09M 0.02% 671
2025
Q3 		$15.4M Sell
153,649
-4,073
-3% -$367K 0.02% 754
2025
Q2 		$13.1M Buy
157,722
+3,392
+2% +$271K 0.02% 685
2025
Q1 		$12.5M Buy
154,330
+5,604
+4% +$501K 0.02% 666
2024
Q4 		$13.4M Sell
148,726
-3,665
-2% -$355K 0.03% 586
2024
Q3 		$15.1M Sell
152,391
-8,014
-5% -$787K 0.03% 523
2024
Q2 		$14.9M Sell
160,405
-4,815
-3% -$432K 0.03% 498
2024
Q1 		$15.7M Buy
165,220
+126,053
+322% +$11.7M 0.04% 475
2023
Q4 		$3.5M Sell
39,167
-17,898
-31% -$1.33M 0.03% 570
2023
Q3 		$4.17M Buy
57,065
+10,116
+22% +$808K 0.04% 472
2023
Q2 		$3.91M Sell
46,949
-1,896
-4% -$159K 0.03% 497
2023
Q1 		$3.72M Sell
48,845
-3,215
-6% -$267K 0.03% 490
2022
Q4 		$4.32M Buy
52,060
+7,587
+17% +$614K 0.04% 430
2022
Q3 		$3.53M Sell
44,473
-503
-1% -$42.4K 0.07% 296
2022
Q2 		$3.34M Sell
44,976
-1,135
-2% -$85.2K 0.05% 356
2022
Q1 		$4.14M Sell
46,111
-1,747
-4% -$161K 0.06% 326
2021
Q4 		$5.36M Buy
47,858
+34,990
+272% +$4.22M 0.08% 269
2021
Q3 		$1.62M Sell
12,868
-556
-4% -$71.6K 0.03% 598
2021
Q2 		$1.82M Buy
13,424
+772
+6% +$101K 0.03% 545
2021
Q1 		$1.72M Buy
12,652
+2,082
+20% +$312K 0.03% 466
2020
Q4 		$1.49M Buy
10,570
+5,091
+93% +$652K 0.03% 529
2020
Q3 		$611K Sell
5,479
-3,127
-36% -$351K 0.05% 340
2020
Q2 		$963K Buy
8,606
+2,987
+53% +$294K 0.09% 243
2020
Q1 		$435K Buy
5,619
+331
+6% +$29.3K 0.05% 327
2019
Q4 		$507K Buy
5,288
+36
+0.7% +$3.11K 0.05% 340
2019
Q3 		$399K Buy
5,252
+1,048
+25% +$87.1K 0.05% 345
2019
Q2 		$371K Buy
+4,204
New +$359K 0.05% 343

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Cetera Investment Advisers's XBI Position: Q2 2026 in Review

Cetera Investment Advisers reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.14% in Q2 2026, selling an estimated $31K and leaving 162,025 shares worth $25.6M. The position accounts for 0.02% of the portfolio, ranked #638.

Cetera Investment Advisers first reported a position in XBI in Q2 2019 and has held it in 29 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Cetera Investment Advisers held 162,025 shares of State Street SPDR S&P Biotech ETF worth $25.6M as of Q2 2026.
  • Cetera Investment Advisers sold 229 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $31K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Cetera Investment Advisers's portfolio in Q2 2026, its #638 holding.
  • Cetera Investment Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and has held it in 29 quarters since.
  • 934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.